Deposition of soluble amyloid-beta onto amyloid templates: with application for the identification of amyloid fibril extension inhibitors
Esler, W.P.; Stimson, E.R.; Mantyh, P.W.; Maggio, J.E.
Methods in Enzymology 309: 350-374
1999
ISSN/ISBN: 0076-6879 PMID: 10507035 DOI: 10.1016/s0076-6879(99)09025-4
Accession: 034697033
Full Text Article emailed within 0-6 h: $19.90
Related References
Sadowski, M.; Pankiewicz, J.; Scholtzova, H.; Ripellino, J.A.; Li, Y.; Schmidt, S.D.; Mathews, P.M.; Fryer, J.D.; Holtzman, D.M.; Sigurdsson, E.M.; Wisniewski, T. 2004: A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice American Journal of Pathology 165(3): 937-948Du, Y.; Wei, X.; Dodel, R.; Sommer, N.; Hampel, H.; Gao, F.; Ma, Z.; Zhao, L.; Oertel, W.H.; Farlow, M. 2003: Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity Brain: a Journal of Neurology 126(Pt 9): 1935-1939
Konno, T. 2001: Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril Biochemistry 40(7): 2148-2154
Linke, R.P. 1982: Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease Clinical Neuropathology 1(4): 172-182
Di Giovanni, S.; Eleuteri, S.; Paleologou, K.E.; Yin, G.; Zweckstetter, M.; Carrupt, P.-A.; Lashuel, H.A. 2010: Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity Journal of Biological Chemistry 285(20): 14941-14954
Skinner, M.; Shirahama, T.; Cohen, A.S.; Deal, C.L. 1982: The association of amyloid P-component (AP) with the amyloid fibril: an updated method for amyloid fibril protein isolation Preparative Biochemistry 12(5): 461-476
Yuan, Q.; Liu, X.; Xian, Y.-F.; Tang, Y.; Zou, J.; Zhang, X.; Huang, P.; Wu, W.; Song, Y.-Q.; Lin, Z.-X. 2020: Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease Molecular Neurobiology 57(1): 278-289
Meng, F.; Marek, P.; Potter, K.J.; Verchere, C.Bruce.; Raleigh, D.P. 2008: Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death Biochemistry 47(22): 6016-6024
Pras, M.; Reshef, T. 1973: The acid soluble fraction of amyloid the protein subunit of the amyloid fibril Peeters, H (Ed ) Protides Of The Biological Fluids Proceedings Of A Colloquia Vol 20 Brugge, Belgium, 1972 Xvi+611p Illus Pergamon Press: Oxford, England; New York, N Y , U S A 103-107
Kametani, F.; Ikeda, S.; Yanagisawa, N.; Ishi, T.; Hanyu, N. 1992: Characterization of a transthyretin-related amyloid fibril protein from cerebral amyloid angiopathy in type i familial amyloid polyneuropathy Journal of the Neurological Sciences 108(2): 178-183
Li, Q.; Gordon, M.; Etienne, M.A.; Hammer, R.P.; Morgan, D. 2008: Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition Cell Transplantation 17(4): 397-408
Murakami, T.; Noguchi, K.; Hachiya, N.; Kametani, F.; Tasaki, M.; Nakaba, S.; Sassa, Y.; Yamashita, T.; Obayashi, K.; Ando, Y.; Hamamura, M.; Kanno, T.; Kawasako, K. 2020: Needle-shaped amyloid deposition in rat mammary gland: evidence of a novel amyloid fibril protein Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 27(1): 25-35
Konno, T. 2001: Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's b(25-35) amyloid fibril Biochemistry (American Chemical Society) 40(7): 48-54
Marín-Argany, M.; Rivera-Hernández, G.; Martí, J.; Villegas, S. 2011: An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway Biochemical Journal 437(1): 25-34
Kirschner, D.A.; Elliott-Bryant, R.; Szumowski, K.E.; Gonnerman, W.A.; Kindy, M.S.; Sipe, J.D.; Cathcart, E.S. 1998: In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice Journal of Structural Biology 124(1): 88-98
Kato, M.; Kinoshita, H.; Enokita, M.; Hori, Y.; Hashimoto, T.; Iwatsubo, T.; Toyo'oka, T. 2007: Analytical method for beta-amyloid fibrils using CE-laser induced fluorescence and its application to screening for inhibitors of beta-amyloid protein aggregation Analytical Chemistry 79(13): 4887-4891
Montañés, Mía.; Casabona, D.; Sarasa, L.; Pesini, P.; Sarasa, M. 2013: Prevention of amyloid-β fibril formation using antibodies against the C-terminal region of amyloid-β1-40 and amyloid-β1-42 Journal of Alzheimer's Disease: Jad 34(1): 133-137
Ogawa, H.; Terazima, M.; Saito, A.; Ohta, K. 1985: The relation between carpal tunnel syndrome and amyloid deposition in the hemodialysis patients immunohistochemical study of the amyloid fibril Japanese Journal of Medicine 24(4): 321
Willem, M.; Dewachter, I.; Smyth, N.; Van Dooren, T.; Borghgraef, P.; Haass, C.; Van Leuven, F. 2004: Beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice American Journal of Pathology 165(5): 1621-1631
Sadowski, M.; Pankiewicz, J.; Wisniewski, T.; Scholtzova, H.; Ripellino, J.A.; Yongsheng, L.I.; Schmidt, S.D.; Mathews, P.M.; Fryer, J.D.; Holtzman, D.M.; Sigurdsson, E.M. 2004: A synthetic peptide blocking the apolipoprotein E/β-amyloid binding mitigates β-amyloid toxicity and fibril formation in vitro and reduces β-amyloid plaques in transgenic mice The American Journal of Pathology 165(3): 937-948